HOOK3-RET:: a novel type of RET/PTC rearrangement in papillary thyroid carcinoma

被引:51
作者
Ciampi, Raffaele
Giordano, Thomas J.
Wikenheiser-Brokamp, Kathryn
Koenig, Ronald J.
Nikiforov, Yuri E.
机构
[1] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA
[2] Univ Cincinnati, Coll Med, Dept Pathol, Cincinnati, OH USA
[3] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA
[5] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA
关键词
D O I
10.1677/ERC-07-0039
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chromosomal rearrangements of the RET proto-oncogene (RETIPTC) are the common feature of papillary thyroid carcinoma (PTC). In this study, we report the identification, cloning, and functional characterization of a novel type of RETIPTC rearrangement that results from the fusion of the 3'-portion of RET coding for the tyrosine kinase (TK) domain of the receptor to the 5'-portion of the Homo sapiens hook homolog 3 (HOOK3) gene. The novel fusion was identified in a case of PTC that revealed a gene expression signature characteristic of RETIPTC on DNA microarray analysis, but was negative for the most common types of RET rearrangement. A fusion product between exon 11 of HOOK3 and exon 12 of RET gene was identified by 5'RACE, and the presence of chimeric HOOK3-RET protein of 88 kDa was detected by western blot analysis with an anti-RET antibody. The protein is predicted to contain a portion of the coiled-coil domains of HOOK3 and the intact TK domain of RET. Expression of the HOOK3-RET cDNA in NIH3T3 cells resulted in the formation of transformed foci and in tumor formation after injection into nude mice, confirming the oncogenic nature of HOOK3-RET.
引用
收藏
页码:445 / 452
页数:8
相关论文
共 40 条
[1]   GDNF family neurotrophic factor signaling: Four masters, one servant? [J].
Airaksinen, MS ;
Titievsky, A ;
Saarma, M .
MOLECULAR AND CELLULAR NEUROSCIENCE, 1999, 13 (05) :313-325
[2]  
Argani P, 1998, MODERN PATHOL, V11, P65
[3]   MOLECULAR CHARACTERIZATION OF A THYROID TUMOR-SPECIFIC TRANSFORMING SEQUENCE FORMED BY THE FUSION OF RET TYROSINE KINASE AND THE REGULATORY SUBUNIT RI-ALPHA OF CYCLIC AMP-DEPENDENT PROTEIN KINASE-A [J].
BONGARZONE, I ;
MONZINI, N ;
BORRELLO, MG ;
CARCANO, C ;
FERRARESI, G ;
ARIGHI, E ;
MONDELLINI, P ;
DELLAPORTA, G ;
PIEROTTI, MA .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (01) :358-366
[4]  
BONGARZONE I, 1994, CANCER RES, V54, P2979
[5]   Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer [J].
Ciampi, R ;
Knauf, JA ;
Kerler, R ;
Gandhi, M ;
Zhu, ZW ;
Nikiforova, MN ;
Rabes, HM ;
Fagin, JA ;
Nikiforov, YE .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (01) :94-101
[6]   Alterations of the BRAF gene in thyroid tumors [J].
Ciampi, R ;
Nikiforov, YE .
ENDOCRINE PATHOLOGY, 2005, 16 (03) :163-171
[7]   RET/PCM-1:: a novel fusion gene in papillary thyroid carcinoma [J].
Corvi, R ;
Berger, N ;
Balczon, R ;
Romeo, G .
ONCOGENE, 2000, 19 (37) :4236-4242
[8]  
De Micco C, 2003, AM J CLIN PATHOL, V120, P803
[9]   Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer [J].
Frattini, M ;
Ferrario, C ;
Bressan, P ;
Balestra, D ;
De Cecco, L ;
Mondellini, P ;
Bongarzone, I ;
Collini, P ;
Gariboldi, M ;
Pilotti, S ;
Pierotti, MA ;
Greco, A .
ONCOGENE, 2004, 23 (44) :7436-7440
[10]  
Fuganti A., 1996, GEOLOGIA TECNICA AMB, V4, P13